-
Review
February 13, 2023
- Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
- Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, et al.
- Clin Mol Hepatol. 2023;29(3):593-604.
Articles in E-pub version are posted online ahead of regular printed publication.
- Editorial
- Adding to the confusion in more than name
- Jacob George
- Received September 18, 2023 Accepted September 18, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0367 [Accepted]
-
View: 51 Download: 3
- From NASH, MAFLD, to SLD: updates of nomenclature and impact on clinical trials
- Ming-Lun Yeh, Ming-Lung Yu
- Received September 15, 2023 Accepted September 18, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0359 [Accepted]
-
View: 80 Download: 17
- Original Article
- Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: a longitudinal real-world study
- Vy H. Nguyen, Isaac Le, Audrey Ha, Richard Hieu Le, Nicholas Ajit Rouillard, Ashley Fong, Surya Gudapati, Jung Eun Park, Mayumi Maeda, Scott Barnett, Ramsey Cheung, Mindie H. Nguyen
- Received June 14, 2023 Accepted September 7, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0205 [Accepted]
-
View: 189 Download: 18
- Review
- Waiting for the changes after the adoption of steatotic liver disease
- Eileen L. Yoon, Dae Won Jun
- Received August 3, 2023 Accepted September 4, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0291 [Accepted]
-
View: 200 Download: 43
- Editorial
- Novel Paradigm in the Treatment of Hepatocellular Carcinoma: Anticipating Breakthroughs with Particle Therapy
- Sang Min Yoon
- Received August 29, 2023 Accepted August 30, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0336 [Accepted]
-
View: 160 Download: 11
- Correspondence
- Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”
- Eileen L. Yoon, Dae Won Jun
- Received August 15, 2023 Accepted August 25, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0310 [Epub ahead of print]
-
View: 122 Download: 4
- Review Article
- Current Evidence and the Potential Role of Proton Beam Therapy for Hepatocellular Carcinoma
- Sung Uk Lee, Tae Hyun Kim
- Received July 27, 2023 Accepted August 27, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0274 [Accepted]
-
View: 113 Download: 12
- Original Article
- Prognostic role of CT analysis using deep learning algorithm in patients with chronic hepatitis B viral infection
- Jeongin Yoo, Heejin Cho, Dong Ho Lee, Eun Ju Cho, Ijin Joo, Sun Kyung Jeon
- Received June 1, 2023 Accepted August 27, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0190 [Accepted]
-
View: 161 Download: 11
- Review
- Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
- Gi-Ae Kim, Joon Ho Moon, Won Kim
- Received July 28, 2023 Accepted August 23, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0277 [Accepted]
-
View: 411 Download: 93
- Letter to the Editor
- Letter regarding “Risk factors in nonalcoholic fatty liver disease”
- Abhijit Pratap, Umesh More, Pradnya Phalak, Anita Deshmukh
- Received July 24, 2023 Accepted August 1, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0268 [Epub ahead of print]
-
View: 197 Download: 9
- Editorial
- Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
- Eugene Han, Yong-ho Lee
- Received July 15, 2023 Accepted August 11, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0250 [Epub ahead of print]
-
View: 263 Download: 29
- Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
- Hyo-Cheol Kim
- Received July 27, 2023 Accepted August 7, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0275 [Epub ahead of print]
-
View: 181 Download: 7
- Letter to the Editor
- Correspondence on Letter regarding “Evidence-based hyponatremia management in liver disease”
- Ji Young Ryu, Seon Ha Baek, Sejoong Kim
- Received July 21, 2023 Accepted August 9, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0261 [Epub ahead of print]
-
View: 250 Download: 6
- Review
- Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma
- Hwa Kyung Byun, Changhwan Kim, Jinsil Seong
- Received June 21, 2023 Accepted August 8, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0217 [Epub ahead of print]
-
View: 343 Download: 25
- Snapshot
- The role of the hepatic autonomic nervous system
- Qiankun Luo, Pan Liu, Yifei Dong, Tao Qin
- Received July 10, 2023 Accepted July 24, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0244 [Epub ahead of print]
-
View: 229 Download: 13
- Review
- Recent advances in the management of hepatocellular carcinoma
- Kamya Sankar, Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen, Andrew E. Hendifar, Ekaterina K. Koltsova, Ju Dong Yang
- Received March 26, 2023 Accepted July 18, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0125 [Epub ahead of print]
-
View: 459 Download: 93
- Letter to the Editor
- Letter regarding “Evidence-based hyponatremia management in liver disease”
- Daphne J. Theodorou, Stavroula J. Theodorou, Ioannis V. Mitselos
- Received June 14, 2023 Accepted June 21, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0204 [Epub ahead of print]
-
View: 319 Download: 15
- Original Article
- Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis
- Ha Il Kim, Jihyun An, Seungbong Han, Ju Hyun Shim
- Received March 29, 2023 Accepted July 4, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0131 [Epub ahead of print]
-
View: 480 Download: 55
- Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
- Hong-Kyu Kim, Sung-Jin Bae, Min Jung Lee, Eun Hee Kim, Hana Park, Hwi Seung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee, Jaewon Choe
- Received January 30, 2023 Accepted July 5, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0035 [Epub ahead of print]
-
View: 922 Download: 118
- Review
- Evidence-based hyponatremia management in liver disease
- Ji Young Ryu, Seon Ha Baek, Sejoong Kim
- Received March 3, 2023 Accepted June 5, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0090 [Epub ahead of print]
-
View: 637 Download: 107
- The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment
- Landon L. Chan, Stephen L. Chan
- Received March 22, 2023 Accepted May 25, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0114 [Epub ahead of print]
-
View: 819 Download: 149 Citation: 1
- Hepatorenal syndrome: Current concepts and future perspectives
- Chan-Young Jung, Jai Won Chang
- Received January 25, 2023 Accepted April 10, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0024 [Epub ahead of print]
-
View: 2985 Download: 993
- Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm
- Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
- Received November 26, 2022 Accepted March 13, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0420 [Epub ahead of print]
-
View: 851 Download: 89 Citations: 2
- Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
- Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
- Received December 2, 2022 Accepted March 7, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0434 [Epub ahead of print]
-
View: 4155 Download: 195 Citation: 1
